92 related articles for article (PubMed ID: 10914252)
21. Nutrition and Crohn's disease: a case study in ambiguity.
Ooi CJ; Podolsky DK
Nutrition; 2000 Jan; 16(1):76-7. PubMed ID: 10674246
[No Abstract] [Full Text] [Related]
22. [Growth of children with Crohn's disease and nutritional therapy].
Ayabe T; Nomura M; Ashida T; Taruishi M; Einami K; Saito Y; Orii F; Chiba A; Fujiki T; Shibata Y
Nihon Shokakibyo Gakkai Zasshi; 1994 Oct; 91(10):1979-85. PubMed ID: 7967135
[No Abstract] [Full Text] [Related]
23. DNA-driven nutritional therapy of inflammatory bowel disease.
Lee G; Buchman AL
Nutrition; 2009 Sep; 25(9):885-91. PubMed ID: 19647622
[TBL] [Abstract][Full Text] [Related]
24. Biologic therapy in Crohn's disease: state of the art.
Jones J; Panaccione R
Curr Opin Gastroenterol; 2008 Jul; 24(4):475-81. PubMed ID: 18622162
[TBL] [Abstract][Full Text] [Related]
25. [Oral aspects of Crohn's disease].
Scheper HJ; Brand HS
Ned Tijdschr Tandheelkd; 2000 Oct; 107(10):413-6. PubMed ID: 11383234
[TBL] [Abstract][Full Text] [Related]
26. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy.
Gavin J; Anderson CE; Bremner AR; Beattie RM
J Hum Nutr Diet; 2005 Oct; 18(5):337-42. PubMed ID: 16150129
[TBL] [Abstract][Full Text] [Related]
27. Crohn's disease: an important differential diagnosis of granulomatous skin diseases.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2009; 19(4):360-4. PubMed ID: 19443301
[TBL] [Abstract][Full Text] [Related]
28. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
29. Gut instinct.
Wood S
Nurs Times; 1998 Feb 25-Mar 3; 94(8):70-2. PubMed ID: 9544073
[No Abstract] [Full Text] [Related]
30. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
[TBL] [Abstract][Full Text] [Related]
31. Risk/benefit strategies must be employed in the management of pediatric Crohn's disease.
Hyams JS
Dig Dis; 2009; 27(3):291-6. PubMed ID: 19786754
[TBL] [Abstract][Full Text] [Related]
32. Annual cost of care for Crohn's disease: a payor perspective.
Feagan BG; Vreeland MG; Larson LR; Bala MV
Am J Gastroenterol; 2000 Aug; 95(8):1955-60. PubMed ID: 10950042
[TBL] [Abstract][Full Text] [Related]
33. Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx".
Rieder F; Hamer O; Gelbmann C; Schölmerich J; Gross V; Feuerbach S; Herfarth H; Rogler G
Z Gastroenterol; 2006 Jul; 44(7):599-602. PubMed ID: 16823701
[TBL] [Abstract][Full Text] [Related]
34. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
[TBL] [Abstract][Full Text] [Related]
35. Immune activation and nutritional status in adult Crohn's disease patients.
Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
[TBL] [Abstract][Full Text] [Related]
36. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
37. Perianal Crohn's disease.
Khaikin M; Chowers Y; Zmora O
Isr Med Assoc J; 2007 Mar; 9(3):163-8. PubMed ID: 17402327
[TBL] [Abstract][Full Text] [Related]
38. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD.
Westcott ED; Mattacks CA; Windsor AC; Knight SC; Pond CM
Ann N Y Acad Sci; 2006 Aug; 1072():395-400. PubMed ID: 17057221
[TBL] [Abstract][Full Text] [Related]
39. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
40. Combining T cells and IL-10: a new therapy for Crohn's disease?
Madsen K
Gastroenterology; 2002 Dec; 123(6):2140-4. PubMed ID: 12454869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
